TNF-A and IL-8 in Consecutive Sputum Samples from Cystic Fibrosis Patients During Antibiotic Treatment

References

• Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches WH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 107582.
   Web of Science ®Google Scholar
• Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br Med J 1995; 310: 1571–2.
   PubMed Web of Science ®Google Scholar
• Kronborg G, Hansen MB, Svenson M, Fomsgaard A, Høiby N, Bendtzen K. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr Pulmonol 1993; 15: 292–7.
   Google Scholar
• Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111–8.
   PubMed Web of Science ®Google Scholar
• Strandvik B. Antibiotic therapy of pulmonary infections in cystic fibrosis. Dosage and dose schedules. Chest 1988; 94: 146–9.
   Google Scholar
• Gilljam H, Malmborg AS, Strandvik B. Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis. Thorax 1985; 41: 641–6.
   Google Scholar
• Ericsson A, Granström M, Möllby R, Strandvik B. Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis. Acta Paediatr Scand 1986; 75: 139–44.
   PubMed Web of Science ®Google Scholar
• Granström M, Ericsson A, Strandvik B, Wretlind B, Pavlovskis OR, Berka R, et al. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr Scand 1984; 73: 772–7.
   Google Scholar
• Solymar L, Aronsson PH, Bake B, Bjure J. Nitrogen single breath test, flow-volume curves and spirometry in healthy children, 7–18 years of age. Eur J Respir Dis 1980; 61: 275–86.
   PubMedGoogle Scholar
• Quanjer PhH. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19 (Suppl 5): 45–51.
   Google Scholar
• Schaedel C, Hjelte H, de Monestrol I, Johannesson M, Kollberg H, Kornfält R, et al. Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden. Clin Genet. 1999; 56: 318–22.
   Google Scholar
• Strandvik B, Hjelte L, Malmborg AS, Widen B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr 1992; 81: 340–4.
   PubMed Web of Science ®Google Scholar
• Strandvik B, Hjelte L, Malmborg AS. Cystic fibrosis pulmonary infection: the Swedish experience. In: Bauernfeind A, Marks MI, Strandvik B, eds. Cystic fibrosis pulmonary infections: lessons from around the world. Basel, Switzerland: Birkhäuser Verlag, 1996, p. 293–302.
   Google Scholar
• Salva PS, Doyle NA, Graham L, Eigen H, Doerschuk CM. TNF-α, IL-8, soluble ICAM-1 and neutrophils in sputum of cystic fibrosis patients. Pediatr Pulmonol 1996; 21: 11–9.
   Google Scholar
• Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 1997; 175: 638–47.
   Google Scholar
• Cusumano V, Tufano MA, Mancuso G, Carbone M, Rossano F, Fera MT, et al. Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes. Infect Immun 1997; 65: 1683–7.
   PubMed Web of Science ®Google Scholar
• Palfreyman RW, Watson ML, Eden C, Smith AW. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect Immun 1997; 65: 617–22.
   PubMed Web of Science ®Google Scholar
• DiMango E, Zar HJ, Bryan R, Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995; 96: 2204–10.
   PubMed Web of Science ®Google Scholar
• Sawitzke AD, Knudtson KL, Cole BC. Bacterial superantigens in disease. In: Roth JA, Bolin CA, Brogden KA, Minion FC, Wannemuehler MJ, eds. Virulence mechanisms of bacterial pathogens. 2nd ed. Washington, DC: ASM Press, 1995, p. 145–69.
   Google Scholar
• Kelly N, Clee S, Nakielna B. Bioactive tumor necrosis factor in the sputa of cystic fibrosis patients. Clin Diagn Lab Immunol 1995; 2: 499–502.
   PubMedGoogle Scholar
• Konstan MW, Hilliard KA, Norvell TM, Berger M. Bron-choalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448–54.
   PubMed Web of Science ®Google Scholar
• Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis. Pediatr Res 1993; 34: 159–61.
   Google Scholar
• Koller DY, Nething I, Otto J, Urbanek R, Eichler I. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity. Am J Respir Crit Care Med 1997; 155: 1050–4.
   Google Scholar
• Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutièrrez JP, Hull J, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997; 156: 1197–204.
   Google Scholar
• Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, et al. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 1998; 153: 921–30.
   PubMed Web of Science ®Google Scholar